RxDoctor Payments Data

Gregory Edens, MD

Family Medicine · Easley, SCNPI 1952365173

Payments from drug & device makers

$5,073in general payments, 2019–2025

Across 407 payments — averaging $12.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$663
  • AbbVie$563
  • Pfizer$467
  • Lilly USA, LLC$441
  • AstraZeneca$339
  • Astellas Pharma US Inc$256
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$4,96898%
  • Education$1052%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,073 in reported general payments places this provider in the 85th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$123,129
Medicare patients
414
Services billed
3,721

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide152$285,732
JardianceEmpagliflozin170$187,688
EliquisApixaban118$107,486
Tresiba Flextouch U-200Insulin Degludec67$69,471
MounjaroTirzepatide55$62,910
LinzessLinaclotide55$46,681
JanuviaSitagliptin Phosphate30$39,932
XareltoRivaroxaban25$37,202
TrulicityDulaglutide21$34,811
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$29,694
Breo ElliptaFluticasone/Vilanterol36$23,562
RybelsusSemaglutide14$22,965
JanumetSitagliptin Phos/Metformin Hcl14$21,429
Janumet XrSitagliptin Phos/Metformin Hcl23$20,745
FarxigaDapagliflozin Propanediol20$18,079

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Wegovy$663$324,203178 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta, Combivent Respimat$215$214,482207 claims
PfizerEliquis$467$107,486118 claims
Lilly USA, LLCMounjaro, Trulicity$441$97,72176 claims
MerckJanuvia, Janumet, Janumet Xr, Dulera$198$88,02083 claims
GSKTrelegy Ellipta, Breo Ellipta$242$53,25767 claims
AbbVieLinzess$563$46,68155 claims
Johnson & JohnsonXarelto$21$37,20225 claims
AstraZenecaFarxiga, Symbicort$339$25,94243 claims
Astellas Pharma US IncMyrbetriq$256$18,06121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Easley

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →